Daikin Industries, Ltd.;Otsuka Pharmaceutical Factory, Inc.
发明人:
申请号：
EP16824084.4
公开号：
EP3323878A4
申请日:
2016.07.14
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
When mammal cells are administered by using a container whose surface in contact with the mammal cells is formed of a fluororesin material at least partially having a -CF 3 terminal group or a container whose surface in contact with the mammal cells is formed of a fluororesin material having a total number of non-fluorinated group terminals and -CF 2 H group terminals in the fluororesin of 70 or less per 1 × 10 6 carbon atoms, or mammal cells are stored or cultured in such a container, the cell adhesion on the container inner surface and the cell survival rate reduction can effectively be suppressed. Therefore, by using these containers, a mammal cell-containing liquid having a high concentration and a high proportion of living cells can be administered, stored or prepared, which contributes to regenerative medicine using the mammal cell-containing liquid (suspension liquid).
